This inventor holds 2 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2008-2011.
Company Filing History:
Years Active: 2008-2011
Title: Prakash Jagivanbhal Dodia: Innovator in Anti-Tubercular Research
Introduction
Prakash Jagivanbhal Dodia is a notable inventor based in Gujarat, India. He has made significant contributions to the field of anti-tubercular research, focusing on the enhancement of anti-tubercular activity through innovative methods. His work has led to the development of novel extracts and processes that show promise in treating tuberculosis.
Latest Patents
Dodia holds 2 patents that highlight his innovative approach to combating tuberculosis. His first patent relates to the enhancement of anti-tubercular activity of an active fraction isolated from a specific source. This invention discloses the non-toxic nature of the fraction and identifies Sucrose as its main constituent. Notably, pure Sucrose has no anti-tubercular activity, indicating that the activity of the fraction resides in one or more minor constituents. The invention also includes a chromatographic technique for separating these minor constituents to explore their activities and structures in detail.
His second patent focuses on herbal extracts of Salicornia species, detailing a process for preparing novel extracts that exhibit anti-tubercular activity. This invention emphasizes the potential use of these extracts in the treatment of tuberculosis, showcasing Dodia's commitment to addressing this critical health issue.
Career Highlights
Prakash Dodia is affiliated with the Council of Scientific and Industrial Research, where he conducts his research and development activities. His work is characterized by a strong emphasis on scientific rigor and innovation, contributing to advancements in medical research.
Collaborations
Dodia has collaborated with notable colleagues, including Bhupendra Dhanvantrai Shethia and Jayant Batukral Pandya. These collaborations have further enriched his research endeavors and have led to significant advancements in the field.
Conclusion
Prakash Jagivanbhal Dodia is a dedicated inventor whose work in anti-tubercular research has the potential to make a significant impact on public health. His innovative patents and collaborations reflect his commitment to finding effective solutions for tuberculosis treatment.